Jupiter Wellness Inc. (JUPW)
Company Description
Jupiter Wellness, Inc. develops cannabidiol (CBD) based medical therapeutics and wellness products.
The company's clinical pipeline includes CaniDermRX (JW-100), a novel topical formulation containing CBD and aspartame for the treatment of eczema, dermatitis, and actinic keratosis; JW-101, a prescription product for the treatment of burns; and JW-200, a non-prescription lotion/lip balm for the treatment of symptoms of cold sores.
It also manufactures, distributes, and markets a line of consumer products, such as CBD-infused sunscreen under the CaniSun brand; CBD-infused skin care lotion under the CaniSkin brand; and products for the dermatological treatments of pain and inflammation under the CaniDermRX brand.
The company was formerly known as CBD Brands, Inc.
Jupiter Wellness, Inc. was incorporated in 2018 and is headquartered in Jupiter, Florida.

Country | United States |
IPO Date | Oct 30, 2020 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Employees | 10 |
CEO | Brian Scott John |
Contact Details
Address: 1061 East Indiantown Road Jupiter, Florida United States | |
Website | https://www.jupiterwellness.com |
Stock Details
Ticker Symbol | JUPW |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001760903 |
CUSIP Number | 48208F105 |
ISIN Number | US48208F1057 |
Employer ID | 83-2455880 |
SIC Code | 2844 |
Key Executives
Name | Position |
---|---|
Brian Scott John | Chief Executive Officer & Executive Director |
David Sandler CSCS, FISSN, FNSCA, HFD, HFS, M.S., MS, RSCC | Chief Operating Officer |
Douglas O. McKinnon | Chief Financial Officer |
Jarrett Boon | Chief Operating Officer |
Jason M. Roth | Chief Operating Officer |
Markita L. Russell | Chief Financial Officer |
Anthony Pedicelli | Director of Marketing |
Dr. Andy Goren M.D. | Chief Medical Officer & Member of Scientific Advisory Board |
Dr. Glynn Wilson Ph.D. | Chief Scientific Officer & Chairman |
Josh Wagner | Chief Revenue Officer |
Neil Luckianow | Chief Commercial Officer |
Richard A. Miller | Sec. |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Apr 16, 2025 | S-1/A | [Amend] Filing |
Apr 10, 2025 | S-1/A | [Amend] Filing |
Apr 10, 2025 | 8-K | Current Report |
Apr 10, 2025 | PREM14A | Filing |
Apr 04, 2025 | 8-K | Current Report |
Apr 04, 2025 | S-1/A | [Amend] Filing |
Mar 31, 2025 | 8-K | Current Report |
Mar 28, 2025 | 10-K | Annual Report |
Mar 19, 2025 | 8-K | Current Report |
Mar 17, 2025 | 424B5 | Filing |